Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Diabetes. 2014 Oct 16;64(4):1202–1210. doi: 10.2337/db14-0737

Figure 6. In vivo effects of AITC.

Figure 6

A. Administration of AITC (15 mg/kg) or vehicle (PBS) by oral gavage caused a significant increase in plasma GLP-1 levels at five minutes in WT mice that was also present in the trpa1−/− (n=6). B. The administration of AITC at 1.5 and 0.15 mg/kg failed to cause any significant increase in plasma GLP-1 levels (n=8-11; two-way unpaired Student’s t-test).